Shares of Amazon.com Inc. (NASDAQ:AMZN) fell as much as 14% to $195 following the company’s third quarter earnings report. The company reported a 73% drop in third quarter earnings at $63 million, or $0.14 a share. Revenue saw a 44% increase to $10.88 million, but spending was even higher. The release of the company’s Kindle Fire helped send spending higher.

Most analysts forecast Amazon’s earnings to be at $0.24 a share and revenue of $10.95 billion for the third quarter. Amazon also released its fourth quarter forecast with revenue of $16.45 billion to $18.65 billion. This is lower than Wall Street’s projection of $18.15 billion.

Amazon’s media business, which includes books, CDs and DVDs, saw a 24% increase in revenue. Amazon’s revenue from electronics and other merchandise rose nearly 60%.

Amazon has been growing fast this year though as it continues to open fulfillment centers around the country at a fast rate.

“You have to go back to year 2000 to see those kind of growth rates,” Chief Financial Officer Tom Szkutak said during their conference call.

CEO Jeff Bazos also gave some details about their Kindle business during the conference call. He stated that September 28 was the Kindle’s, “biggest order day ever” as the company released several new Kindle models including the Kndle Fire.

Amazon expects to have a good quarter during the holiday season later this year.

Unisys Corporation (NYSE:UIS) shares are posting strong gains today rising 31% to $26.30 per share. Volume has traded fairly heavy with over 6.2 million shares exchanging hands in trading today. The basis for this increase comes from news that 3Q net income was $78.6 million, or $1.63 per share. This marks a stark increase from the previous year where net income was $28.3 million or $.65 per share. This is more that $.70 per share higher than forecast by analysts.

Revenue increased by 6% to $1.02 billion also besting analysts forecast of $937.7 million. This was not the only news that had investors bustling and looking to acquire shares. Unisys announced that it has been awarded a contract for more than $10 million over 10 years to install Google Applications for the U.S. Department of Energy’s Idaho National Laboratory. This marks a strong partnership between Google Inc. and Unisys and could lead to many other future contracts.

About Unisys Corporation:

Unisys Corporation operates as an information technology (IT) company worldwide. It operates in two segments, services and technology. The services segment provides outsourcing services, including management of customers data centers, computer servers, and end-user computing environments

Netflix shares plunged this morning after many negative comments from analysts following the company’s disappointing fourth quarter outlook. Netflix also disclosed that expansion overseas will limit its profitability in the first half of 2012.

Analyst Tony Wible of Janney Capital Markets was one of many analysts to downgrade Netflix to a sell and had this to say about Netflix. “We believe the [Netflix business] model is unsustainable, as the company faces rising costs that it hoped it could pass on to its subscribers,” Wible added, “The company has paid exorbitant prices for content while painting itself as a cheap rental service. Simply put, the company’s brand does not fit with its large/growing content obligations.”

Some analysts are calling this a major reset as Netflix shares were trading as high as $300 a few months ago.

In its fourth quarter outlook, Netflix said its earnings will be in the range of $0.36 to $0.70 a share on revenue of $816 million to $845 million. This is well below what many analysts were predicting which was profits of $1.05 a share and revenue of $923 million. At the end of December, Netflix expects to have about 20.8 million subscribers. This is down from 21.4 million in the third quarter. Netflix also canceled spinning off its DVD unit into a separate entity called Qwikster.

Shares of Netflix are down over 36% at $76 a share right now on heavy volume. Over 14 million shares have been traded already this morning, double its average volume.

The diversified technology giant 3M (NYSE:MMM) reported its third quarter earnings on Tuesday with a dimmer outlook for the rest of the year. 3M reported earnings of $1.52 per share, down 1% from the previous year, against expectations of $1.61 per share. 3M, the maker of Scotch tape and Post-It notes, reported sales of $7.5 billion, which was up 9.6% year-over-year, while operating margins grew 21%. 3M said it now expects earnings to be in the range of $5.85 to $5.95 per share versus a previous forecast of $6.10 to $6.25.

“The business environment remains challenging, as the economic softening that we experienced late in the second quarter continued into the third,” 3M CEO George W. Buckley said in a statement.

“Looking ahead, early evidence suggests slower growth will persist through year end, therefore we are responding to lower demand with aggressive cost management and operational discipline in developed economies,” Buckley said.

3M is based out of Maplewood, MN ,said it was hit hard by the LCD TV market and slowing momentum in other electronic markets.

3M reported global sales at $27 billion in 2010 and operates in 65 countries. The company, founded in 1902, has been a leading innovator of products that have literally changed the world. 3M employs approximately 80,000 people worldwide. 3M sells its products in nearly 200 countries.

Shares of 3M were trading at 76.60 down 6.72% at 9:44 am ET on Tuesday.

Dupont Co. (NYSE:DD) posted higher third quarter profit and sales than analysts had expected. The company also raised its full year forecast as well. DuPont is based out of Wilmington, Delaware.

DuPont reported net income climbed 23%to $452 million, or 48 cents a share, from $367 million, or 40 cents, a year earlier. Earnings excluding costs related to the acquisition of Danisco A/S, Imperilis herbicide tree damage, and a seed license payment were 69 cents, surpassing the 56-cent average of 14 estimates compiled by Bloomberg Survey. Net sales advanced 32 percent to $9.24 billion from $7 billion.

DuPont raised prices 15% across its portfolio during the quarter, with volume rising 1%.

Full-year earnings will be $3.97 to $4.05 a share, compared with a July prediction of $3.90 to $4.05, DuPont said. The forecast excludes costs for the acquisition of Danisco and a licensing payment.

DuPont was founded in 1802. The company is the most valuable chemical company in the United States and operates in 90 countries. DuPont makes chemicals used in all markets from transportation, apparel, construction, etc. down to the products consumers use on a daily basis.

“The resilience and diversity of DuPont’s business portfolio was evident in our strong third quarter results. Despite turbulent global economic and market conditions, we delivered solid growth through innovative products and process technologies, disciplined execution and continued productivity gains,” said DuPont Chair & CEO Ellen Kullman. “Our portfolio is further strengthened by the rapid integration of Danisco, continued capacity expansions and selective growth investments across many of our businesses.”

Shares of DuPont were at 47.22, up 2.45% in the pre-market.

United Parcel Service (NYSE:UPS) released its third quarter earnings. The world’s largest package delivery company said third-quarter net income rose to $1.04 billion, or $1.06 per share, from $991 million, or 99 cents a share, a year earlier. Analysts had forecasted $1.05 a share. UPS reports its revenue rose 18% to $13.17 billion.

“UPS produced another solid quarter of earnings growth against the backdrop of a deceleration in exports from Asia and a challenging global economic environment,” Chief Executive Officer Scott Davis said in a statement.

Domestic shipping volume averaged 12.74 million packages a day, little changed from 12.73 million packages a year ago. Operating margins improved on higher yields, or revenue per package, as well as on more efficient networks, the company said. International shipping volume averaged 2.34 million a day, up from 2.24 million a day.

Revenue in this segment rose more than 14%, twice the rate in the domestic segment, driven by 6.5% growth in export volume. The value of packages handled by UPS’s trucks and planes each year is equivalent to about 6% of U.S. gross domestic product and 2% of global GDP.

In September, UPS introduced PharmaPort 360, the latest innovation in cold-chain shipping solutions designed specifically for the healthcare industry. This unique temperature-controlled container offers unparalleled shipment monitoring and product protection for pharmaceuticals, vaccines and biologics.

“We are reiterating our 2011 guidance for UPS adjusted diluted earnings per share to a range of $4.15-to-$4.40,” said Kurt Kuehn, UPS’s chief financial officer. “UPS continues to deliver strong financial results in today’s global economic environment as customers benefit from the logistics solutions that only UPS offers.”

Adolor Corporation (Nasdaq:ADLR) shares have seen a huge jump today climbing nearly 142% to $4.66 per share. Volume has been very heavy as 13.4 million shares have exchanged hands in trading today. All of this action comes on the announcement that Cubist Pharmaceuticals plans on acquiring Adolor in a deal worth up to $415 million.

Cubist Pharmaceuticals (NASDAQ:CBST) announced Monday that they will acquire Adolor for $4.25 per share. There is a a contingency payment possible for an additional $4.50 per share if certain FDA regulatory approvals are achieved. Adolor is currently in the testing phase for a treatment for opiod induced constipation. The contingency payment is based on the approval and development of this drug on a commercial level.

According to Cubist CEO Michael Bonney, “This transaction is an excellent strategic fit for Cubist and the latest milestone in what has been a transformational year for the company.” Both boards of directors approved the acquisition and the deal is expected to close out in the fourth quarter of this year. CBST is currently down nearly 2% on the acquisition news.

About Adolor Corporation:

Adolor Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of novel prescription pain and pain management products.

About Cubist Pharmaceuticals:

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.